Karak FE - Search Results

1

Renal cell carcinoma management: real-world practice and challenges at a national level.

Ghosn M, Kattan J, Karak FE, Ghanem H, Debs J, Ibrahim K, Shamseddine A. Ghosn M, et al. Among authors: karak fe. Future Oncol. 2023 Apr;19(12):863-872. doi: 10.2217/fon-2021-1189. Epub 2023 May 17. Future Oncol. 2023. PMID: 37194701 Review.

2

Informational Needs of Women with Breast Cancer Treated with Chemotherapy.

Abi Nader E, Kourie HR, Ghosn M, Karak FE, Kattan J, Chahine G, Nasr F. Abi Nader E, et al. Among authors: karak fe. Asian Pac J Cancer Prev. 2016;17(4):1797-800. doi: 10.7314/apjcp.2016.17.4.1797. Asian Pac J Cancer Prev. 2016. PMID: 27221855 Free article.

3

Immune checkpoint inhibitors renal side effects and management.

Rassy EE, Kourie HR, Rizkallah J, Karak FE, Hanna C, Chelala DN, Ghosn M. Rassy EE, et al. Among authors: karak fe. Immunotherapy. 2016 Dec;8(12):1417-1425. doi: 10.2217/imt-2016-0099. Immunotherapy. 2016. PMID: 28000536 Review.

4

Where do the immune checkpoint inhibitors stand in the management of triple negative breast cancer?

Rassy EE, Karak FE, Ghosn M. Rassy EE, et al. Among authors: karak fe. Immunotherapy. 2018 Feb 1;10(4):247-250. doi: 10.2217/imt-2017-0171. Immunotherapy. 2018. PMID: 29421978 Free article. No abstract available.

5

Untreated chronic lymphocytic leukemia in Lebanese patients: an observational study using standard karyotyping and FISH.

Rassy EE, Chebly A, Korban R, Semaan W, Bakouny Z, Assi T, Kourie HR, Karak FE, Chouery E, Kattan J. Rassy EE, et al. Among authors: karak fe. Int J Hematol Oncol. 2017 Dec;6(4):105-111. doi: 10.2217/ijh-2017-0019. Epub 2017 Dec 21. Int J Hematol Oncol. 2017. PMID: 30302231 Free PMC article.

6

Comprehensive tumor profiling-guided therapy in rare or refractory solid cancer: A feasibility study in daily clinical practice.

Ibrahim T, Ahmadie A, Rassy E, Karak FE, Hanna C, Farhat F, Kattan J, Ghosn M. Ibrahim T, et al. Among authors: karak fe. Bull Cancer. 2020 Apr;107(4):410-416. doi: 10.1016/j.bulcan.2019.12.010. Epub 2020 Mar 4. Bull Cancer. 2020. PMID: 32145962

7

TRK inhibition in soft tissue sarcomas: A comprehensive review.

Assi T, Rassy E, Nassereddine H, Farhat F, Karak FE, Kattan J, Ghosn M. Assi T, et al. Among authors: karak fe. Semin Oncol. 2020 Feb;47(1):73-84. doi: 10.1053/j.seminoncol.2020.02.009. Epub 2020 Mar 9. Semin Oncol. 2020. PMID: 32201016 Review.

8

Should we screen patients with hematologic malignancies for COVID-19?

Rassy E, Khoury-Abboud RM, Ibrahim N, Assi T, Samra B, Hanna C, Karak FE, Ghosn M. Rassy E, et al. Among authors: karak fe. Hematol Oncol. 2020 Dec;38(5):648-653. doi: 10.1002/hon.2780. Epub 2020 Aug 8. Hematol Oncol. 2020. PMID: 32779823 Free PMC article. Review.

9

Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey.

Moujaess E, Zeid NB, Samaha R, Sawan J, Kourie H, Labaki C, Chebel R, Chahine G, Karak FE, Nasr F, Ghosn M, Wakim J, Kattan J. Moujaess E, et al. Among authors: karak fe. Future Oncol. 2021 Nov;17(31):4071-4079. doi: 10.2217/fon-2021-0265. Epub 2021 Aug 2. Future Oncol. 2021. PMID: 34337969 Free PMC article.

10

Palbociclib and letrozole in hormone-receptor positive advanced breast cancer: Predictive response and prognostic factors.

Gharib KE, Macaron W, Kattan J, Salloum MA, Farhat F, Smith M, Karak FE. Gharib KE, et al. Among authors: karak fe. Curr Probl Cancer. 2022 Jun;46(3):100859. doi: 10.1016/j.currproblcancer.2022.100859. Epub 2022 Mar 28. Curr Probl Cancer. 2022. PMID: 35378469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page